Epstein.Interpretación de biopsias de la próstata, 6ed

 INTERPRETACIÓN DE BIOPSIAS DE LA PRÓSTATA

210

59. D’Amico AV, Wu Y, Chen MH, et al. Perineural invasion as a predictor of biochemical outcome fo- llowing radical prostatectomy for select men with clinically localized prostate cancer. J Urol . 2001;165(1):126–129. 60. Rubin MA, Bismar TA, Curtis S, et al. Prostate needle biopsy reporting: how are the surgical mem- bers of the society of urologic oncology using pathology reports to guide treatment of prostate cancer patients? Am J Surg Pathol . 2004;28(7):946–952. 61. Chung JS, Choi HY, Song HR, et al. Preoperative nomograms for predicting extracapsular extension in Korean men with localized prostate cancer: a multi-institutional clinicopathologic study. J Korean Med Sci . 2010;25(10):1443–1448. 62. Pak S, Park S, Ryu J, et al. Preoperative factors predictive of posterolateral extracapsular extension after radical prostatectomy. Korean J Urol . 2013;54(12):824–829. 63. Epstein JI, Lecksell K, Carter HB. Prostate cancer sampled on sextant needle biopsy: significance of cancer on multiple cores from different areas of the prostate. Urology . 1999;54(2):291–294. 64. Mamawala MM, Rao K, Landis P, et al. Risk prediction tool for grade re-classification in men with favourable-risk prostate cancer on active surveillance. BJU Int . 2017;120(1):25–31. 65. Kryvenko ON, Carter HB, Trock BJ, et al. Biopsy criteria for determining appropriateness for active surveillance in the modern era. Urology . 2014;83(4):869–874. 66. Maru N, Ohori M, Kattan MW, et al. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. Hum Pathol . 2001;32(8):828–833. 67. Merrilees AD, Bethwaite PB, Russell GL, et al. Parameters of perineural invasion in radical prostatec- tomy specimens lack prognostic significance. Mod Pathol . 2008;21(9):1095–1100. 68. Thorson P, Vollmer RT, Arcangeli C, et al. Minimal carcinoma in prostate needle biopsy specimens: diagnostic features and radical prostatectomy follow-up. Mod Pathol . 1998;11(6):543–551. 69. Vargas SO, Jiroutek M, Welch WR, et al. Perineural invasion in prostate needle biopsy specimens. Correlation with extraprostatic extension at resection. Am J Clin Pathol . 1999;111(2):223–228. 70. Yu HH, Song DY, Tsai YY, et al. Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy. Urology . 2007; 70(1):111–116. 71. Shariat SF, Karakiewicz PI, Roehrborn CG, et al. An updated catalog of prostate cancer predictive tools. Cancer . 2008;113(11):3075–3099. 72. Truong M, Rais-Bahrami S, Nix JW, et al. Perineural invasion by prostate cancer on MR/US fusion targeted biopsy is associated with extraprostatic extension and early biochemical recurrence after ra- dical prostatectomy. Hum Pathol . 2017;66:206–211. 73. Weight CJ, Ciezki JP, Reddy CA, et al. Perineural invasion on prostate needle biopsy does not predict biochemical failure following brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys . 2006;65(2):347–350. 74. Vora SA, Wong WW, Schild SE, et al. Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys . 2007;68(4):1053–1058. 75. Beard C, Schultz D, Loffredo M, et al. Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys . 2006;66(2):403–407. 76. Zhang LJ, Wu B, Zha ZL, et al. Perineural invasion as an independent predictor of biochemical re- currence in prostate cancer following radical prostatectomy or radiotherapy: a systematic review and meta-analysis. BMC Urol . 2018;18(1):5. 77. Peng LC, Narang AK, Gergis C, et al. Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy. Urol Oncol . 2018;36(6):309.e7–309.e14. 78. Marina O, Gustafson GS, Kestin LL, et al. Comparison of dose-escalated, image-guided radiothe- rapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients. Brachytherapy . 2014;13(1):59–67. SAMPLE